Psychology Today | 25.09.2026 12:03
Three ADHD medications have reached American patients in the past five years, and a fourth was approved this July. For a field that spent two decades cycling the same molecules through new delivery systems, that is a genuinely unusual stretch. It has also produced a wave of questions in my office, most of which reduce to one: Should I switch?
